Literature DB >> 19353223

Genetic variants of methionine metabolism and X-ALD phenotype generation: results of a new study sample.

Alexander Semmler1, Xinhua Bao, Guangna Cao, Wolfgang Köhler, Michael Weller, Patrick Aubourg, Michael Linnebank.   

Abstract

X-linked adrenoleukodystrophy (X-ALD) is the most common inherited leukodystrophy. Nevertheless, no genotype-phenotype correlation has been established so far. Unidentified modifier genes or other cofactors are suspected to modulate phenotype and prognosis. We recently described polymorphisms of methionine metabolism as possible disease modifiers in X-ALD. To retest these findings, we analyzed 172 new DNA samples of X-ALD patients from different populations (France, Germany, USA, China) by genotyping eight genetic variants of methionine metabolism, including DHFR c.594+59del19bp, CBS c.844_855ins68, MTR c.2756A>G, MTHFR c.677C>T and c.1298A>C, MTRR c.60A>G, RFC1 c.80G>A, and Tc2 c.776C>G. We compared three X-ALD phenotypes: childhood-onset cerebral demyelinating inflammatory type (CCALD; n = 82), adulthood onset with focal cerebral demyelination (ACALD; n = 38), and adulthood onset without cerebral demyelination (AMN; n = 52). The association of genotypes and phenotypes was analyzed with univariate two-sided Pearson's chi(2). In the comparison between AMN and CCALD, the G allele of Tc2 c.776C>G was associated with X-ALD phenotypes (chi(2) = 6.1; P = 0.048). The prevalence of the GG genotype of Tc2 c.776C>G was higher in patients with CNS demyelination compared to those without CNS demyelination (chi(2) = 4.42; P = 0.036). The GG genotype was also more frequent in CCALD compared to AMN (chi(2) = 4.7; P = 0.031). The other polymorphisms did not show any significant associations in this study sample. Whereas the influence of other polymorphisms of methionine metabolism was not confirmed, the present study supports the previously made observation that the Tc2 genotype contributes to X-ALD phenotype generation.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19353223     DOI: 10.1007/s00415-009-5114-6

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  16 in total

Review 1.  Mouse models and genetic modifiers in X-linked adrenoleukodystrophy.

Authors:  Ann K Heinzer; Martina C McGuinness; Jyh-Feng Lu; O Colin Stine; Heming Wei; Mark Van der Vlies; Gao-Xiang Dong; James Powers; Paul A Watkins; Kirby D Smith
Journal:  Adv Exp Med Biol       Date:  2003       Impact factor: 2.622

2.  The cystathionine beta-synthase variant c.844_845ins68 protects against CNS demyelination in X-linked adrenoleukodystrophy.

Authors:  Michael Linnebank; Alexander Semmler; Wim J Kleijer; Marianne L T van der Sterre; Jutta Gärtner; Klaus Fliessbach; Piotr Sokolowski; Wolfgang Köhler; Uwe Schlegel; Thomas Klockgether; Ronald J A Wanders; Stephan Schmidt; Ullrich Wüllner; Stephan Kemp
Journal:  Hum Mutat       Date:  2006-10       Impact factor: 4.878

3.  Association of genetic variants of methionine metabolism with methotrexate-induced CNS white matter changes in patients with primary CNS lymphoma.

Authors:  Michael Linnebank; Susanna Moskau; Annika Jürgens; Matthias Simon; Alexander Semmler; Katjana Orlopp; Axel Glasmacher; Christopher Bangard; Marlies Vogt-Schaden; Horst Urbach; Ingo G H Schmidt-Wolf; Hendrik Pels; Uwe Schlegel
Journal:  Neuro Oncol       Date:  2008-09-19       Impact factor: 12.300

Review 4.  Clinical and genetic aspects of X-linked adrenoleukodystrophy.

Authors:  J Gärtner; A Braun; A Holzinger; P Roerig; H G Lenard; A A Roscher
Journal:  Neuropediatrics       Date:  1998-02       Impact factor: 1.947

5.  Demyelination and single-carbon transfer pathway metabolites during the treatment of acute lymphoblastic leukemia: CSF studies.

Authors:  R Surtees; J Clelland; I Hann
Journal:  J Clin Oncol       Date:  1998-04       Impact factor: 44.544

Review 6.  Homocysteine metabolism and various consequences of folate deficiency.

Authors:  Flaubert Tchantchou
Journal:  J Alzheimers Dis       Date:  2006-08       Impact factor: 4.472

Review 7.  Mutations in the adrenoleukodystrophy gene.

Authors:  A Dodd; S A Rowland; S L Hawkes; M A Kennedy; D R Love
Journal:  Hum Mutat       Date:  1997       Impact factor: 4.878

8.  Reduced vitamin B12 binding by transcobalamin II increases the risk of neural tube defects.

Authors:  L A Afman; N M Van Der Put; C M Thomas; J M Trijbels; H J Blom
Journal:  QJM       Date:  2001-03

9.  Homocysteine and carotid intima-media thickness in a german population: lack of clinical relevance.

Authors:  Michael Linnebank; Susanna Moskau; Susan Farmand; Klaus Fliessbach; Heike Kölsch; Monika Bös; Christoph Grothe; Dietmar Becker; Ursula Harbrecht; Christoph Pohl; Ullrich Wüllner; Thomas Klockgether
Journal:  Stroke       Date:  2006-09-28       Impact factor: 7.914

10.  Methionine metabolism and phenotypic variability in X-linked adrenoleukodystrophy.

Authors:  M Linnebank; S Kemp; R J A Wanders; W J Kleijer; M L T van der Sterre; J Gärtner; K Fliessbach; A Semmler; P Sokolowski; W Köhler; U Schlegel; S Schmidt; T Klockgether; U Wüllner
Journal:  Neurology       Date:  2006-02-14       Impact factor: 9.910

View more
  4 in total

Review 1.  Adrenoleukodystrophy - neuroendocrine pathogenesis and redefinition of natural history.

Authors:  Stephan Kemp; Irene C Huffnagel; Gabor E Linthorst; Ronald J Wanders; Marc Engelen
Journal:  Nat Rev Endocrinol       Date:  2016-06-17       Impact factor: 43.330

Review 2.  The genetic landscape of X-linked adrenoleukodystrophy: inheritance, mutations, modifier genes, and diagnosis.

Authors:  Christoph Wiesinger; Florian S Eichler; Johannes Berger
Journal:  Appl Clin Genet       Date:  2015-05-02

Review 3.  Deciphering the modifiers for phenotypic variability of X-linked adrenoleukodystrophy.

Authors:  Shruti V Palakuzhiyil; Rita Christopher; Sadanandavalli Retnaswami Chandra
Journal:  World J Biol Chem       Date:  2020-11-27

4.  Association of transcobalamin c. 776C>G with overall survival in patients with primary central nervous system lymphoma.

Authors:  M Linnebank; S Moskau; A Kowoll; A Semmler; C Bangard; M Vogt-Schaden; G Egerer; G Schackert; H Reichmann; I G H Schmidt-Wolf; H Pels; U Schlegel
Journal:  Br J Cancer       Date:  2012-10-25       Impact factor: 7.640

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.